Literature DB >> 16038048

Risk factors for primary liver carcinoma in Chinese population.

Rui-Hong Luo1, Zhi-Xin Zhao, Xu-Yu Zhou, Zhi-Liang Gao, Ji-Lu Yao.   

Abstract

AIM: To evaluate the risk factors for primary liver carcinoma (PLC) in Chinese population.
METHODS: Chinese Biomedical Literature Database, China Hospital Knowledge Database and MEDLINE were searched. All the related literatures were screened, and the risk factors for PLC in Chinese population were studied. Heterogeneity was evaluated by odds ratio (OR) q test. Combined OR and its 95% confidence interval (95%CI) were calculated, the association between the investigated risk factors and PLC was determined. Validity and bias of the findings were evaluated by sensitivity analysis and funnel plot analysis respectively.
RESULTS: Fifty-five of one hundred and ninety identified studies were accepted according to the inclusive criteria. Ten factors related to PLC were demonstrated by sensitive analysis and funnel plot analysis. They were cirrhosis (OR = 11.97, P = 0.000), HBV infection (OR = 11.34, P = 0.000), HCV infection (OR = 4.28, P = 0.000), family history of liver cancer (OR = 3.49, P = 0.000), unstable emotion (OR = 2.20, P = 0.000), depressed characters (OR = 3.07, P = 0.000), aflatoxin (OR = 1.80, P = 0.000), alcoholic (OR = 1.88, P = 0.000), intake of musty food (OR = 1.87, P = 0.000) and drinking contaminated water from pond (OR = 1.77, P = 0.003).
CONCLUSION: The main risk factors for PLC in China are liver diseases, family history of liver carcinoma, poor psychic status, aflatoxin, and some unhealthy behaviors.

Entities:  

Mesh:

Year:  2005        PMID: 16038048      PMCID: PMC4434676          DOI: 10.3748/wjg.v11.i28.4431

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  3 in total

1.  Liver cancer in low and middle income countries.

Authors:  Andrew J Hall; Christopher P Wild
Journal:  BMJ       Date:  2003-05-10

2.  [Meta-analysis of the risk factors on lung cancer in Chinese people].

Authors:  Hong-yan Yao; Lu-yuan Shi
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2003-01

3.  Guidelines for reading case-control studies.

Authors:  M J Lichtenstein; C D Mulrow; P C Elwood
Journal:  J Chronic Dis       Date:  1987
  3 in total
  21 in total

1.  Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.

Authors:  Xing Liu; Aileen Baecker; Ming Wu; Jin-Yi Zhou; Jie Yang; Ren-Qiang Han; Pei-Hua Wang; Zi-Yi Jin; Ai-Min Liu; Xiaoping Gu; Xiao-Feng Zhang; Xu-Shan Wang; Ming Su; Xu Hu; Zheng Sun; Gang Li; Alan Fu; Su Yon Jung; Lina Mu; Na He; Liming Li; Jin-Kou Zhao; Zuo-Feng Zhang
Journal:  Liver Int       Date:  2019-07-10       Impact factor: 5.828

2.  Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B.

Authors:  Wenmei Fan; Bingyi Shi; Hongshan Wei; Guosheng Du; Shujing Song
Journal:  Virus Genes       Date:  2010-12-16       Impact factor: 2.332

3.  Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet.

Authors:  Kelly E Mercer; Casey F Pulliam; Kim B Pedersen; Leah Hennings; Martin Jj Ronis
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-05

4.  Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production.

Authors:  ShiHai Zhang; Jing Zhou; CuiLing Zhang; HuiWen Wu; Yi Wang; JianMin Bian; Jun Guo; XiangYang Wu
Journal:  Med Oncol       Date:  2011-07-20       Impact factor: 3.064

5.  Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.

Authors:  Jyh-Der Leu; I-Feng Lin; Ying-Fang Sun; Su-Mei Chen; Chih-Chao Liu; Yi-Jang Lee
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

6.  A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.

Authors:  Tao-Tao Liu; Ying Fang; Hui Xiong; Tao-Yang Chen; Zheng-Pin Ni; Jian-Feng Luo; Nai-Qing Zhao; Xi-Zhong Shen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

7.  Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male Mice.

Authors:  Kelly E Mercer; Casey Pulliam; Leah Hennings; Keith Lai; Mario Cleves; Ellen Jones; Richard R Drake; Martin Ronis
Journal:  Cancer Prev Res (Phila)       Date:  2016-03-22

8.  Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?

Authors:  Jiawu Li; Wenwu Ling; Shuang Chen; Lulu Yang; Lin Ma; Qiang Lu; Yan Luo
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

9.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

10.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.